George Sands/LinkedIn, Pierre Elias/columbia.edu
Mar 8, 2026, 15:41
George Sands: AI Screening Tool for Early Detection of Heart Disease
George Sands, Former Senior Director at Pfizer, shared a post on LinkedIn:
“This is a phenomenal development, led by cardiologist Pierre Elias, at Columbia, where an ortho patient, without know cardio symptoms, was found to have a cardiology condition that was treated within the 7 days of diagnosis by this AI screening tool.
The future is here!
It will help patients and the clinicians who care for them. Bravo and thanks to Dr. Elias’s team.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids